SCHUCHERT JOSEPH S
Transactions
50
Companies
3
Filings
3
CIK
0001034430
Research Summary
AI-generated from SEC filings & financial news
Joseph S. Schuchert
Joseph S. Schuchert is a private equity executive affiliated with Kelso & Company in New York, appearing as a Section 16 reporting person and 10% owner representative for Kelso-managed investment vehicles. His SEC filings name him in connection with portfolio companies including Earle M. Jorgensen Company, FairPoint Communications and Endo Health Solutions.[1]
Career Background
- Representative of Kelso & Company on Section 16 filings, acting as a reporting person for Kelso investment vehicles.[1]
- Named on Form 3/Form 4 filings that identify him as a Director and 10% owner representative for Earle M. Jorgensen Company.[2]
- Identified in registration and proxy-related SEC materials linking Kelso-managed funds to FairPoint Communications, with Schuchert listed among Kelso-affiliated reporting individuals.[3]
- Listed on Section 16 filings for Endo (formerly Endo Pharmaceuticals / Endo Health Solutions) as a Kelso-affiliated reporting person and 10% owner representative.[4]
Current Positions
- Section 16 reporting person and 10% owner representative for Kelso-managed investment vehicles that hold or held interests in portfolio companies.[1]
- Named on SEC filings as the Kelso-affiliated reporting individual for issuer filings tied to Earle M. Jorgensen Company (issuer).[2]
- Named on SEC filings as a Kelso-affiliated reporting individual for issuer filings tied to FairPoint Communications (ticker: FRP) and Endo (historical ticker: ENDP).[3]
SEC Filing Context
- Public Section 16 filings associated with Mr. Schuchert show extensive Form 3/4 activity as the reporting person for Kelso investment vehicles; filings reflect substantial transactional volume across multiple portfolio issuers.[1]
- Kelso & Company is documented as the investment manager/affiliate behind the reporting group named on these filings, providing the corporate context for Schuchert’s reporting role.[5]
Recent Transactions
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−896→ 16,041,574 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.00/sh−1,309→ 17,390,061 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−440→ 17,403,042 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−972→ 17,391,370 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.42/sh−9,284→ 16,031,083 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−972→ 17,391,370 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−9,769→ 17,393,274 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−9,769→ 17,393,274 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.42/sh−10,065→ 17,379,996 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−932→ 17,392,341 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−406→ 16,052,340 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−9,011→ 16,043,330 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−440→ 17,403,042 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.00/sh−1,309→ 17,390,061 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.42/sh−10,065→ 17,379,996 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−932→ 17,392,341 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.00/sh−1,309→ 17,390,061 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−972→ 17,391,370 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−932→ 17,392,341 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.42/sh−10,065→ 17,379,996 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−440→ 17,403,042 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.00/sh−1,309→ 17,390,061 total - Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−9,769→ 17,393,274 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$3.00/sh−1,207→ 16,040,367 total - Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-11-21$2.42/sh−860→ 16,042,470 total - Exercise of In-Money
Companies
3Recent Filings
3Address
C/O KELSO & COMPANY 320 PARK AVENUE
NEW YORK, NY, 10022